Glyconics Launches with FTIR Technology to Detect COPD, Other Respiratory Diseases | GenomeWeb

NEW YORK (GenomeWeb) – Glyconics, a UK firm using infrared spectroscopy to diagnose respiratory diseases, said today that it recently secured a contract from the Small Business Research Initiative for Healthcare to validate its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.